focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
...
Yes, I would tend to agree. But this company is undervalued and moves very quickly. Any sniff of a deal and we will be above 2 in a jiffy. Bit of patience required.
Hi Ezeo - this has been very quiet re Brazil for some time, not even a mention about the elapsed period for additional 20% interest in Brazil Tungsten. Happy to hold and have been accumulating at these levels. The money invested in Brazil Tungsten was used to ramp up production, so should be looking at good upside. Of course we also have a small interest in HH.
Another undervalued share here - more than 100% upside for fair value
FINANCIAL HIGHLIGHTS · Group revenue increased 5.9% to $9.1m (H1 2014:$8.6m) - Supermarket Retail revenue increased 9.3% to $8.4m (H1 2014: $7.7m) driven by higher sales of consumable products - As expected, Health Sciences revenue decreased to $0.3m (H1 2014: $0.9m) following the termination of the Onset Dermatologics partnership agreement, as previously announced, in December 2014 - Other revenue increased to $0.4m (H1 2014: nil) and represents fees paid by third parties to gain letters of access to the Active Chlorine Biocidal Products Regulation (BPR) dossier · Gross margin decreased to 24.5% (H1 2014: 28.2%) due to increased service costs within Supermarket Retail - Company remains focused on improving margins in the mid- term and is investing in improving the reliability of its generators and updating early versions of its concentrate delivery system · Operating expenses increased to $6.9m (H1 2014: $6.1m) due primarily to investment in research, development and regulatory activities in Health Sciences and Supermarket Retail · EBITDA* loss $3.8m (H1 2014 loss: $2.2m) · Cash and cash equivalents, net of debt ($0.2m), were $16.3m as at 30 June 2015 (as at 31 December 2014: $20.7m, net of debt) *** Current mcap sits at £10m - cash and cash equivalants at USD 16m + HY1 sales of USD $9.1m
Looks undervalued here! NAV 76p including cash and equivalents
This morning. What a great RNS! £8m mcap against a record £26m sales on the order book this year + additional contracts already in the pipeline 12m shares in float. This will move quickly and should be much higher to gain fair value. GLA
How little action there is here given positive developments in the company and 2 large director buys. Strong H2 figures expected. Bottom drawer for now
Looks like I may have timed this just right yesterday Astonishingly low mcap and free float. Co restructured and potential newsflow looks good going into 2016 GLA holders old and new
Yes i had the same line. Hopefully this comes good for both of us. Makes no sense selling at 9.5p tbh. As i say have been looking at this for a month or so, didn't notice the big drop the other day, but today's RNS flagged PAA up and thought too good an opportunity to pass by. GL
Appreciate for long termers it has been painful. I picked up this end of Sept when interims were RNS'd. Clearly the stock has hit near bottom. I like the fact the board has restructured, cut overheads and focussed on the music which seems to be making inroads. Looking at David Ciclitira credentials he has a good track record and is well connected. Of course if it is a big IF, but if a deal can be done on the golf then this will be seen as bargain prices. Even without golf the music play will generate cash. Happy to hold on for news Have you had any communication with David Ciclitira before?
wow lovely turnaround this morning
On 3 buys. Not going to take a lot to move this Cheap as chips and 3m shares in float
Had my eye On PAA for a while. Tiny tiny mcap and very small free float Music division delivering as promised. If PAA can secure 2016 golf championship then this will be at many multiples of today's price
in yesterday to take a small position. Alot of questions hanging over the share but on a risk reward basis looks good
a few tweets from DL today re ISDX liquidity. Nice to see a bit of blue
Hi Michael, No, I found the same website as you. I have tried contacting Evo as to how timescales and progress is going but no reply. It has been a while since news flow, but i do feel very optimistic with Evo. Some whisperings on HH stocks as well, so will be interesting to see what follows. Very low Mcap here and I'm also a buyer at these levels. GL
I agree. Surely an update on Brazil really is overdue. I do think this has the potential to go much than where we are today. Happy to buy more and hold whilst we are here
First day of dealings on ISDX
Solid base here, will move quickly on any decent volume